PowderJect to begin auction after £450m offer from US
Monday 21 October 2002
PowderJect Pharmaceuticals, the controversial vaccines company which is supplying smallpox jabs to the Government, will admit this morning that it has attracted bid interest from at least three companies.
Its bankers, CSFB, are set to launch an auction of the company, with the bidding starting at £450m, or 500p a share, after an indicative offer from the US company Chiron. That represents a 96 per cent premium to last week's share price, and would net PowderJect's founder and chairman, Paul Drayson, £36m for his stake.
The company dismissed Chiron's bid as opportunistic, and said it would not agree a deal at that price.
PowderJect shares have collapsed from 566p at the start of the year to just 255p, as it has become embroiled in a political row over suggestions of cash-for-contracts. Mr Drayson gave £50,000 to the Labour Party just weeks before the Government awarded PowderJect a £32m contract to supply the smallpox vaccine for use in the event of a bioterrorist attack. The group has also had to issue a profit warning after recalling its BCG jab for tuberculosis. Mr Drayson established PowderJect in 1993 to commercialise novel technology for needle-free injections which had been developed at Oxford University, and which has proved disappointing so far. The business was floated in 1997 and has since bought a string of vaccines companies that transformed it from a cash-burning biotech to a company expected to make £20m this year.
PowderJect is one of an elite band of profitable biotechs, but it is still pouring money into research on a novel, needle-free device for injecting powdered DNA-based vaccines through the skin.
California-based Chiron is an $8bn (£5.2bn) pharmaceuticals group listed on Nasdaq. Its products include blood screening kits and cancer drugs, as well as vaccines. Its offer is seen as the most far advanced of the three to have been made so far, but none has begun due diligence.
PowderJect will warn shareholders that talks with potential bidders are at an early stage and that there is no guarantee formal offers will be received. A spokesman said: "Until these offers came in, PowderJect saw itself as the predator, not the prey. It has made a number of acquisitions in the past, and was planning to make a number more."
- 1 I was a Woman Against Feminism too
- 2 Is Gideon Levy the most hated man in Israel or just the most heroic?
- 3 Chief Ebola doctor in Sierra Leone has contracted the deadly disease himself
- 4 Students offered grants if they tweet pro-Israeli propaganda
- 5 Israel has discovered that it's no longer so easy to get away with murder in the age of social media
Lana Del Rey: 'I have slept with a lot of guys in the industry'
Vladimir Putin employs a full-time food taster to ensure his meals aren't poisoned
Chief Ebola doctor in Sierra Leone has contracted the deadly disease himself
Students offered grants if they tweet pro-Israeli propaganda
Israel-Gaza conflict: Israel may have committed war crimes, says UN human rights chief
Malaysia Airlines MH17 crash: Vladimir Putin is given 'one last chance' to end hostilities in Ukraine
The 'scroungers’ fight back: The welfare claimants battling to alter stereotypes
The truth about conspiracy theories is that some require considering
Malaysia Airlines MH17 crash: Ukrainian military jet was flying close to passenger plane before it was shot down, says Russian officer
Malaysia Airlines MH17 crash: Massive rise in sale of British arms to Russia
Malaysia Airlines MH17 crash: victims’ bodies bundled in black bags and loaded onto trains
iJobs Money & Business
£350 - £400 per day: Orgtel: Test Lead, London, Banking, Financial Reporting, ...
£375 - £400 per day + competitive: Orgtel: My client, a leading bank, is curre...
£350 - £400 per day: Orgtel: PMO Analyst - Banking - London - £350 -£400 per d...
£300 - £350 per day + competitive: Orgtel: Cost Reporting Manager - MI Packs -...